Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Abacavir + 3TC + ZDV vs 3TC + ZDV in ART-Naive HIV-1
NCT00002389Phase 3Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of abacavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00002389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002389.